Retrospective analysis of icotinib neoadjuvant therapy of 63 lung cancer patients.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study aims to explore the feasibility of icotinib neoadjuvant therapy for nonsmall cell lung cancer (NSCLC).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Indian J Cancer

Title: Indian journal of cancer

Publisher: Medknow

ISSN (Electronic): 1998-4774

ISSN (Print): 0019-509X

Publication date (Electronic): December 5 2017

Volume: 54

Issue: 1

Affiliations

[1 ] Department of Thoracic Surgery, PLA General Hospital, Beijing 100853, China.

Article

Publisher Item ID: IndianJournalofCancer_2017_54_1_215_219585

DOI: 10.4103/0019-509X.219585

PubMed ID: 29199694

SO-VID: 29e44468-332e-4229-abf3-d68290f73207

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1

Different efficacy in the non-small cell lung cancer patient with bilateral synchronous lesions treated with neoadjuvant gefitinib therapy: a case report
Authors: Wenxing DU, Yandong Zhao, Yunpeng Xuan …

See all cited by